Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - Voyager Therapeutics, Inc. | vygr-20151231ex312a90cde.htm |
EX-31.1 - EX-31.1 - Voyager Therapeutics, Inc. | vygr-20151231ex31183d6c3.htm |
EX-32.1 - EX-32.1 - Voyager Therapeutics, Inc. | vygr-20151231ex321e67f23.htm |
XML - IDEA: XBRL DOCUMENT - Voyager Therapeutics, Inc. | R9999.htm |
10-K - 10-K - Voyager Therapeutics, Inc. | vygr-20151231x10k.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-207958) pertaining to the 2014 Stock Option and Grant Plan, the 2015 Stock Option and Incentive Plan, and the 2015 Employee Stock Purchase Plan of Voyager Therapeutics, Inc., of our report dated March 17, 2016 with respect to the consolidated financial statements of Voyager Therapeutics, Inc. included in this Annual Report (Form 10-K) of Voyager Therapeutics, Inc. for the year ended December 31, 2015.
/s/Ernst & Young LLP
Boston, Massachusetts
March 17, 2016